Expansion, repositioning, acquisition, a major digital investment or a category shift can create meaningful advantage. They can also lock the company into the wrong assumptions at scale.
MAXPRIMACY helps leadership test the market logic behind high-consequence decisions before significant capital, time, reputation or organisational energy is committed.
01 Opportunity
Is the market opportunity strong enough?
02 Competitive Reality
What conditions will the company actually face?
03 Position
Can the move create a stronger reason to choose?
04 Execution
What must be built for the strategy to work?
05 Risk
Which assumptions can invalidate the decision?
A strategic move often looks logical from inside the company. The risk is that internal conviction can hide weak demand, underestimated competitive barriers, unclear positioning, unrealistic acquisition economics or execution requirements that have not yet been made visible.
The larger the commitment, the more valuable it becomes to challenge the assumptions before execution begins.
Whether the company is entering, repositioning, acquiring or investing, the strategic question is similar: which assumptions must hold for the move to strengthen the company’s market position?
Entering a new geography, segment or market where demand and competitive conditions are not yet fully understood.
Market ExpansionChanging what the company wants to be known for, who it wants to serve or which comparison it wants to create.
RepositioningRebuilding a website, acquisition system, content platform or digital infrastructure before the growth architecture is clear.
Major Digital InvestmentLaunching a significant new offer or creating a new category logic that changes how the company competes.
Product or Category ExpansionEvaluating whether another company, capability, audience or route to market actually strengthens the strategic position.
Acquisition or Strategic PartnershipMost strategic decisions contain a small number of assumptions capable of changing the entire outcome. Those assumptions deserve more attention than the details that are merely easy to research.
MAXPRIMACY identifies and tests the assumptions with the greatest potential to invalidate the move, change its sequence or materially alter the investment required.
The purpose is not to eliminate risk. It is to distinguish acceptable risk from avoidable risk created by weak assumptions.
Strategic clarity improves when leadership can define the decision, the evidence required, the conditions for success and the signals that would argue against proceeding.
If every strategic review ends by validating the original plan, it is not reducing decision risk. The process must allow the evidence to change the scope, sequence, timing or direction of the move.
Evidence before commitment.
Decision before execution.
Conditions before scale.
A company can have a timeline, budget, vendor list, media plan and implementation roadmap while the central market assumption remains weak. Operational detail makes a plan feel concrete. It does not make the strategic premise correct.
Execution planning should become more detailed as the underlying thesis becomes more defensible.
The outcome is not automatically approval. The evidence may support proceeding, narrowing the commitment, testing first, changing the strategy or stopping the move.
The opportunity, positioning, competitive conditions and execution requirements justify the planned commitment.
ProceedA smaller geography, segment, offer or investment creates a better risk-adjusted first step.
Narrow the MoveThe thesis is promising, but one or more assumptions should be validated before larger investment.
Test Before CommitmentThe opportunity may remain attractive, but the category, position, offer or execution model should change.
Change the StrategyThe current evidence does not justify the commitment, timing or opportunity cost.
Do Not Proceed YetA focused investment decision may require only a small number of critical evidence streams. A major repositioning or expansion may require deeper work across market demand, competition, positioning, visibility and commercial architecture.
We do not maximise research volume. We identify the evidence that can materially change the decision.
The work can be narrow or multi-capability. The scope should match the uncertainty that matters, not the size of the available toolkit.
The output should make the strategic thesis more explicit, identify the assumptions carrying the greatest risk and define what should happen before additional commitment.
The exact deliverables depend on the nature of the move and the evidence required to support or challenge it.
Where useful, the work can also include the Demand Map, Competitive Gap Map, Positioning Map, Visibility Precedence Map or Growth Architecture Map.
We begin with the decision leadership is considering, identify the assumptions with the greatest downside and then connect the strongest evidence to the scale, sequence and conditions of the move.
It is improving the quality of the decision before the organisation becomes too committed to change direction cheaply.
Evidence before commitment.
Conditions before scale.
Clarity before irreversible cost.
The MAXPRIMACY Diagnostic or a focused strategic engagement can examine demand, competition, positioning, visibility, commercial architecture and decision risk before significant commitment is made.
Tell us what decision is ahead, what level of commitment it involves, which assumptions currently support it and what would make getting it wrong expensive.